Skip Navigation

European Heart Journal 2000 21(15):1204-1206; doi:10.1053/euhj.1999.2049
Copyright © 2000 by the European Society of Cardiology.
This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (9)
Right arrowRequest Permissions
Google Scholar
Right arrow Articles by Torp-Pedersen, C.
Right arrow Articles by Camm, A.J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Torp-Pedersen, C.
Right arrow Articles by Camm, A.J.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Hotline Editorial

Dofetilide for the treatment of atrial fibrillation in patients with congestive heart failure

C. Torp-Pedersena, M. Møllerb, L. Købera and A.J. Cammc

a Gentofte, University Hospital, Copenhagen, Denmark
b Odense University Hospital, Odense, Denmark
c St. George's Hospital, London, U.K.

References

  1. Kannel WB, Wolf PA, Benjamin EJ, Levy D. Prevalence, incidence, prognosis, and predisposing conditions for atrial fibrillation: population-based estimates. Am J Cardiol. 1998;82:2N–9N[CrossRef][ISI][Medline]
  2. Benjamin EJ, Wolf PA, D'Agostino RB, Silbershatz H, Kannel WB, Levy D. Impact of atrial fibrillation on the risk of death: the Framingham Heart Study. Circulation. 1998;98:946–952[Abstract/Free Full Text]
  3. Middlekauff HR, Stevenson WG, Stevenson LW. Prognostic significance of atrial fibrillation in advanced heart failure. A study of 390 patients. Circulation. 1991;84:40–48[Abstract/Free Full Text]
  4. Cairns JA, Connolly SJ, Roberts R, Gent M. Randomised trial of outcome after myocardial infarction in patients with frequent or repetitive ventricular premature depolarisations: CAMIAT. Canadian Amiodarone Myocardial Infarction Arrhythmia Trial Investigators. Lancet. 1997;349:675–682[CrossRef][ISI][Medline]
  5. Julian DG, Camm AJ, Frangin G. Randomised trial of effect of amiodarone on mortality in patients with left-ventricular dysfunction after recent myocardial infarction: EMIAT. European Myocardial Infarct Amiodarone Trial Investigators. Lancet. 1997;349:667–674[CrossRef][ISI][Medline]
  6. Connolly SJ. Evidence-based analysis of amiodarone efficacy and safety. Circulation. 1999;1000:2025–2034
  7. Greenbaum RA, Campbell TJ, Channer KS. Conversion of atrial fibrillation and maintenance of sinus rhythm by dofetilide. The EMERALD (European and Australian Multicenter Evaluative Research on Atrial Fibrillation Dofetilide) study (Abstr). Circulation. 1998;98:1633
  8. Flaker GC, Blackshear JL, McBride R, Kronmal RA, Halperin JL, Hart RG. Antiarrhythmic drug therapy and cardiac mortality in atrial fibrillation. The Stroke Prevention in Atrial Fibrillation Investigators. J Am Coll Cardiol. 1992;20:527–532[Abstract]
  9. Echt DS, Liebson PR, Mitchell LB. Mortality and morbidity in patients receiving encainide, flecainide or placebo. The Cardiac Arrhythmia Suppression Trial. N Engl J Med. 1991;324:781–788[Abstract]
  10. Waldo AL, Camm AJ, deRuyter H. Effect of d-sotalol on morality in patients with left ventricular dysfunction after recent and remote myocardial infarction. Lancet. 1996;348:7–12[CrossRef][ISI][Medline]
  11. N Engl J Med. 1997;336:525–533[Abstract/Free Full Text]
  12. Lancet. 1999;353:2001–2007[CrossRef][ISI][Medline]
  13. Lancet. 1999;353:9–13[CrossRef][ISI][Medline]
  14. Coplen SE, Antman EM, Berlin JA, Hewitt P, Chalmers TC. Efficacy and safety of quinidine therapy for maintenance of sinus rhythm after cardioversion. A meta-analysis of randomized control trials. Circulation. 1990;82:1106–1116[Abstract/Free Full Text]
  15. Torp-Pedersen C, Møller M, Bloch-Thomsen PE. Dofetilide in patients with congestive heart failure and left ventricular dysfunction. Danish Investigations of Arrhythmia and Mortality on dofetilide Study Group. N Engl J Med. 1999;341:857–865[Abstract/Free Full Text]

Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
 J Am Coll CardiolHome page
A. Mazur, M. E. Anderson, S. Bonney, and D. M. Roden
Pause-dependent polymorphic ventricular tachycardia during long-term treatment with dofetilide: A placebo-controlled, implantable cardioverter-defibrillator-based evaluation
J. Am. Coll. Cardiol., March 15, 2001; 37(4): 1100 - 1105.
[Abstract] [Full Text] [PDF]

Home page
 J Am Coll CardiolHome page
M. R. Lauer
Dofetilide: is the treatment worse than the disease?
J. Am. Coll. Cardiol., March 15, 2001; 37(4): 1106 - 1110.
[Full Text] [PDF]

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (9)
Right arrowRequest Permissions
Google Scholar
Right arrow Articles by Torp-Pedersen, C.
Right arrow Articles by Camm, A.J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Torp-Pedersen, C.
Right arrow Articles by Camm, A.J.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?